Effectiveness of sequential lines of biologic and targeted small-molecule drugs in psoriatic arthritis: a systematic review.

导出 LinkOut

翻译打印收藏纠错

第一作者： Charlotte E,Gollins

第一单位： Department of Dermatology, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.;Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath, Bath, UK.

作者： Charlotte E,Gollins ^[1] ; Rosie,Vincent ^[2] ; Caoimhe,Fahy ^[3] ; Neil,McHugh ^[4] ; Mel,Brooke ^[5] ; William,Tillett ^[6]

作者单位： Department of Dermatology, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.;Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath, Bath, UK. ^[1] Department of Dermatology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK. ^[2] Department of Dermatology, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK. ^[3] Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath, Bath, UK. ^[4] British Psoriatic Arthritis Consortium (BritPACT), Bath Institute for Rheumatic Diseases, Royal United Hospital, Bath, UK. ^[5] Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath, Bath, UK.;Royal National Hospital for Rheumatic Diseases, Bath, UK. ^[6]

关键词 bDMARD biological therapies psoriatic arthritis sequential line systematic review

主题词关节炎, 牛皮癣(Arthritis, Psoriatic);人类(Humans);抗风湿药(Antirheumatic Agents);生物制品(Biological Products);治疗结果(Treatment Outcome)

DOI 10.1093/rheumatology/keae006

PMID 38243715

发布时间 2024-11-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交